Efficacy of early rituximab treatment in anti-mGluR1 encephalitis: a case report
We experienced a case of anti-mGluR1 encephalitis with increased cerebellar blood flow, where early RTX administration led to a favorable outcome. Its early use, as an acute treatment and for maintenance, may help prevent recurrence and contribute to a positive prognosis.
Authors
- Ichiro Yabe (ORCID: https://orcid.org/0000-0002-1734-7997)
- Shintaro Fujii (ORCID: https://orcid.org/0009-0003-5155-2593)
- Akira Takekoshi (ORCID: https://orcid.org/0000-0002-7640-2239)
- Akihiko Kudo (ORCID: https://orcid.org/0000-0002-2630-5991)
- S. N. Nakamura (ORCID: https://orcid.org/0009-0008-4706-6505)
- Akio Kimura (ORCID: https://orcid.org/0000-0003-0383-2008)
- Hiroaki Yaguchi (ORCID: https://orcid.org/0000-0001-6643-8740)
- Takayoshi Shimohata (ORCID: https://orcid.org/0000-0002-8788-9089)
- Nobuaki Yoshikura (ORCID: https://orcid.org/0000-0001-8903-8600)
- Kazuhiro Horiuchi (ORCID: https://orcid.org/0000-0002-7040-3273)
- Kazuki Yamada (ORCID: https://orcid.org/0000-0001-8263-0011)
- Taichi Nomura
Institutions
- Hokkaido University (JP)
- Hakodate National Hospital (JP)
- Gifu University (JP)
Publication Details
- Journal
- BMC Neurology
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1186/s12883-025-04345-8
- Citations
- 2
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78